✦ LIBER ✦
6005 PIK3CA, BRAF and KRAS mutations and outcome prediction in chemorefractory metastatic colorectal cancer (mCRC) patients treated with EGFR targeting monoclonal antibodies (MoAbs): results of a European Consortium
✍ Scribed by Tejpar, S.; De Roock, W.
- Book ID
- 122030977
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 47 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.